ORPHA:926
Acatalasemia
Also known as: Catalase deficiency
Query health: suspect — Only one of 2 strategies returned hits (phrase).
Publications
738
78.8th percentile
Trials
0
Interventional, condition-specific
Researchers
859
Distinct authors in sample
Gene link
CAT
Strong
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare inborn error of metabolism characterized by a deficiency in erythrocyte catalase, an responsible for the breakdown of hydrogen peroxide. The disorder is usually asymptomatic but may be associated with oral ulcerations and gangrene, or diabetes mellitus and atherosclerosis in certain populations.
How rare: 1-9 / 100 000 — about one to nine people per hundred thousand.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0013571
- MeSH:D020642
- OMIM:614097
- UMLS:C0268419
- NCIT:C84526
Additional Mondo synonyms (3)
acatalasemia · acatalasia · catalase deficiency
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
No matched interventional trial; the gene is known and literature exists — preclinical or natural-history work may still be the practical next step.
- Gene identifiedPresent
Strong — CAT
- LiteraturePresent
738 matched papers (202 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (CAT).
GenCC classification: Strong.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
738
738 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
738 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
202 in the last 10 years · medium confidence · 78.8th percentile (publications denominator)
Phrase hits: 738 · MeSH hits: 0
Who's working on it?
859
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01
- 02Ogata M10 papers · 2008
Department of Public Health, Okayama University Medical School, Japan.
Papers in Europe PMC - 03Masuoka N9 papers · 2020
Department of Life Science, Okayama University of Science, Okayama 700-0005, Japan.
Papers in Europe PMC - 04Wang DH9 papers · 2020
Department of Public Health, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, 700-8558, Okayama, Japan, dahong@md.okayama-u.ac.jp.
Papers in Europe PMC - 05Nagy T7 papers · 2015
Department of Biomedical Laboratory and Imaging Science, Medical and Health Science Center, University of Debrecen, P.O. Box 55, Debrecen H-4012, Hungary.
Papers in Europe PMC - 06Makino H6 papers · 2012Papers in Europe PMC
- 07Ogino K6 papers · 2021
Department of Environmental Medicine, Kochi Medical School, Kohasu, Oko-cho, Nankoku City, Kochi, 783-8505, Japan. Electronic address: kogino@kochi-u.ac.jp.
Papers in Europe PMC - 08Sugiyama H6 papers · 2012Papers in Europe PMC
- 09Maeshima Y5 papers · 2012Papers in Europe PMC
- 10Park C5 papers · 2025
Department of Biomedical Science and Engineering, Institute of AI-Medical Science, GRI, Gwangju Institute of Science and Technology, Gwangju, 61005, Republic of Korea.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
medium confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Acatalasemia" OR "Catalase deficiency" OR "acatalasia"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Acatalasemia" OR "Catalase deficiency" OR "acatalasia" OR "CAT"
Recall-expansion terms: CAT
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: suspect — strategies attempted: phrase, recall-expansion; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is short or not clearly distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T15:56:10.323Z